We compared the concentrations of CSF PGRN and NFL in RIS patients with the concentrations in healthy controls and in patients at different disease stages and with different subtypes of treatment-naive MS in the absence of an acute clinical relapse. The gene discussed is NEFL; the disease is myeloid sarcoma.